KBC Group NV lifted its stake in Select Medical Holdings Co. (NYSE:SEM – Free Report) by 14.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,883 shares of the health services provider’s stock after acquiring an additional 1,833 shares during the period. KBC Group NV’s holdings in Select Medical were worth $281,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of SEM. Kingsview Wealth Management LLC bought a new position in Select Medical during the third quarter valued at about $1,927,000. JPMorgan Chase & Co. increased its position in shares of Select Medical by 9.7% during the third quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock valued at $14,516,000 after purchasing an additional 36,905 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of Select Medical in the third quarter valued at $1,592,000. Argent Capital Management LLC lifted its position in Select Medical by 79.8% in the fourth quarter. Argent Capital Management LLC now owns 55,144 shares of the health services provider’s stock worth $1,039,000 after purchasing an additional 24,471 shares during the period. Finally, Geode Capital Management LLC boosted its stake in Select Medical by 2.0% during the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after buying an additional 46,880 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.
Wall Street Analyst Weigh In
SEM has been the subject of a number of analyst reports. Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research note on Monday, January 27th. Royal Bank of Canada increased their price objective on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Finally, UBS Group reduced their target price on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $39.50.
Select Medical Trading Up 2.7 %
NYSE:SEM opened at $20.20 on Tuesday. The business’s 50-day simple moving average is $19.83 and its 200-day simple moving average is $29.83. Select Medical Holdings Co. has a fifty-two week low of $18.02 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The stock has a market capitalization of $2.61 billion, a PE ratio of 9.44, a price-to-earnings-growth ratio of 0.66 and a beta of 1.45.
Insider Activity at Select Medical
In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now directly owns 30,356 shares of the company’s stock, valued at $605,602.20. This represents a 14.12 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. 17.50% of the stock is owned by insiders.
About Select Medical
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles
- Five stocks we like better than Select Medical
- How to Capture the Benefits of Dividend Increases
- How to Invest in Small Cap Stocks
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- These Are the Dividend Stocks Insiders Bought in January
- Manufacturing Stocks Investing
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM – Free Report).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.